Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System

New Fourier 80 for High NMR Data Quality with TopSpin Software for Any Chemistry Lab BERLIN, Germany – August 25, 2019 – At EUROISMAR 2019, Bruker today announced the European launch of the Fourier 80 system, a next-generation, high-performance 80 MHz Fourier Transform nuclear magnetic resonance (FT-NMR) benchtop spectrometer. The Fourier 80 has been designed for organic or medicinal chemistry... Read more

New Handheld Analyzer Uses Laser-Induced Breakdown Spectroscopy for Fast, More Accurate Carbon Measurement in the Field

New Handheld Analyzer Uses Laser-Induced Breakdown Spectroscopy for Fast, More Accurate Carbon Measurement in the Field Thermo Scientific Niton Apollo handheld LIBS analyzer provides true mobility and enhances productivity for material verification TEWKSBURY, Mass., Aug. 19, 2019 /PRNewswire/ — For petrochemical plants, fabricators, scrap recyclers and quality control departments seeking to measure low concentrations of carbon... Read more

Consolidated Financial Statements for the First Quarter Ended June 30, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Automating Data Processing in Cancer Research

APEER is helping researchers to analyze data faster and with higher precision An important aspect of cancer research is understanding why some cancer cells escape chemotherapy and become even more aggressive and resistant to treatment. At the University of Vilnius in Lithuania, Prof. Valius Mindaugas and Nadežda Dreižė use confocal microscopy to understand the impact... Read more

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients SANTA CLARA, Calif., July 31, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC... Read more

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 31 July 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more